Lead the global shift to prevention, wellbeing, and community health.
Prevention is the Future of Healthcare
The world is facing a profound health and economic challenge: rising demand on health systems, escalating chronic disease, and mounting costs. But a solution is emerging. Prevention, wellbeing, and community health are no longer “nice-to-have” concepts—they are essential strategies for sustainable healthcare and inclusive economic growth.
By 2030, prevention represents a $12 trillion market opportunity, reshaping industries from healthcare to finance, wellness, and culture. At the heart of this shift lies social prescribing.
What is Social Prescribing?
Social prescribing is a transformative approach to health and wellbeing that connects people to non-clinical community support—such as arts, culture, nature, physical activity, volunteering, and more.
It moves care beyond medicine by addressing the social, emotional, and practical needs that underpin health.
The Global Social Prescribing Alliance (GSPA) brings together governments, health systems, businesses, and civil society to embed social prescribing into national and global health strategies.
The NHS Neighbourhood Health Model: A Blueprint for Industry Partnerships
In the UK, the NHS neighbourhood health model demonstrates how community-powered care can work at scale. By organising services around local populations of 30,000–50,000 people, this model fosters closer collaboration between GPs, community groups, voluntary organisations, and local authorities.
For industry, this provides a unique opportunity:
- Local Testbeds: Pilot digital tools, wellbeing programmes, and new services in real-world community ecosystems.
- Scalable Infrastructure: Align innovations with NHS-backed frameworks that are designed to grow nationally and internationally.
- Shared Value: Co-create solutions that simultaneously reduce demand on hospitals, improve population wellbeing, and generate economic value. The NHS neighbourhood model shows how prevention and social prescribing can be embedded at the local level, offering a powerful entry point for businesses and investors to contribute to global health transformation.
Why Industry Should Care
The future of healthcare is shifting:
-
From treatment to prevention
-
From hospital beds to community assets
-
From fragmented services to collaborative ecosystems This creates a multi-billion dollar opportunity for forward-thinking businesses across technology, health, finance, arts, and lifestyle sectors.
Opportunities for Industry
HealthTech & Digital Innovation
- The global digital health market is expected to reach $660 billion by 2025 (Statista).
- Huge potential to embed social prescribing in electronic health records, referral systems, and personalised wellbeing platforms.
Lifestyle, Wellness & Sport
- The global wellness economy was valued at $5.6 trillion in 2023, forecast to reach $8.5 trillion by 2027 (Global Wellness Institute).
- Social prescribing opens referral pathways from healthcare to gyms, wellbeing apps, mindfulness services, and nature-based therapies.
Arts, Culture & Nature
- Cultural prescribing programmes reduce GP visits by 37% and A&E attendance by 27% (UK NHS studies).
- The global creative economy already represents over 3% of global GDP and is set to grow as a pillar of preventative health.
Finance, Insurance & Investment
- Preventable diseases will cost the global economy $47 trillion in lost output between 2010–2030 (World Economic Forum).
- Social prescribing provides opportunities to align investment portfolios with ESG and SDG goals, while supporting scalable, community-based health interventions.
Workforce & Education
- Mental ill health is the leading cause of long-term sickness absence globally.
- Social prescribing-based workplace wellbeing programmes improve retention, resilience, and productivity.
Value Creation & Investment Opportunities
Social prescribing presents a compelling case for value-based investment:
- New markets in healthtech, wellness, creative therapies, training, and local infrastructure.
- Tangible returns: Every £1 invested in social prescribing generates up to £3.42 in return for the NHS (UK Department of Health).
- Social impact: Measurable outcomes aligned with SDG 3 (Good Health and Wellbeing), ESG frameworks, and inclusive economic growth.
A Word from Leadership
“We have an unprecedented opportunity to move from illness to wellness, from treatment to prevention, and from fragmented systems to thriving neighbourhoods. The NHS neighbourhood model shows what’s possible—now we need industry, governments, and communities to come together to build the future of health.” — Gareth Presch, CEO, Global Social Prescribing Alliance
Join Us – Let’s Build the Future of Health, Together
The Global Social Prescribing Alliance is actively seeking industry partners to:
-
Co-create scalable solutions for health and wellbeing
-
Support innovation pilots in cities, regions, and NHS neighbourhoods
-
Join global forums, working groups, and summits
-
Invest in evidence-based prevention strategies Whether you’re a startup or a global brand, there’s a place for you in this movement.
Partner With Us
Are you ready to be part of the global shift toward community-powered health? Join the GSPA and unlock opportunities across prevention, wellbeing, and inclusive growth.